Find A Physician
Return to Robert M. Ellsworth Ophthalmic Oncology Center Overview
More on Robert M. Ellsworth Ophthalmic Oncology Center
Hospital News
Return to Robert M. Ellsworth Ophthalmic Oncology Center Overview
More on Robert M. Ellsworth Ophthalmic Oncology Center
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Columbia University Medical Center Launches Vaccine Trial For Previously Untreated Metastatic Colorectal Cancer Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- COX-2 Inhibitor May Boost Cancer Treatment, NewYork Weill Cornell Study Shows
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Latest Cancer Findings at American Society of Clinical Oncology (ASCO) Meeting
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at American Society of Clinical Oncology 44th Annual Meeting
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- The Seventh Issue of Cancer Prevention Has Arrived!
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
- Weill Cornell Researchers Announce New Gene Therapy Strategy To Promote Hair Growth
Research and Clinical Trials
Return to Robert M. Ellsworth Ophthalmic Oncology Center Overview
More on Robert M. Ellsworth Ophthalmic Oncology Center
Health Library
Return to Robert M. Ellsworth Ophthalmic Oncology Center Overview
More on Robert M. Ellsworth Ophthalmic Oncology Center
Clinical Services
Return to Robert M. Ellsworth Ophthalmic Oncology Center Overview
More on Robert M. Ellsworth Ophthalmic Oncology Center
- Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Head and Neck Surgery
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Lung Cancer
- Mesothelioma
- Oncology (Cancer)
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Robert M. Ellsworth Ophthalmic Oncology Center
The Robert M. Ellsworth Ophthalmic Oncology Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the world's oldest and largest center for the diagnosis and treatment of eye cancer (retinoblastoma) in children . This Center's genetic counselor is assigned exclusively to retinoblastoma and is involved in the clinical management and education of patients. The Center is an active source of academic work, with more than 350 papers, book chapters, books, and audio- and videotapes published. In the past decade the Center has pioneered the use of peri-ocular chemotherapy to eliminate the need for systemic chemotherapy in retinoblastoma; pioneered the use of the Diopexy laser for treatment of retinoblastoma; developed a new classification scheme for extraocular retinoblastoma; and performed the world's first case of preimplantation genetic diagnosis for retinoblastoma. The role of a virus in causing some of these cancers has also been elucidated. The Center's director has been the principle investigator in a 20 year, prospective National Institutes of Health sponsored, multicenter, randomized clinical trial for ocular melanoma: The Collaborative Ocular Melanoma Study (COMS). This study has already demonstrated that supplemental preoperative external beam radiation for large ocular melanomas that are to be enucleated is not needed; and that for medium sized melanomas, episcleral brachytherapy is as effective as enucleation for survival.
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Columbia University Medical Center Launches Vaccine Trial For Previously Untreated Metastatic Colorectal Cancer Patients More
